From: Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?
 | Progression-free survival | Cause-specific survival | Overall survival | ||||||
---|---|---|---|---|---|---|---|---|---|
 | HR | CI (5-95%) | p | HR | CI (5-95%) | p | HR | CI (5-95%) | p |
Age (>65 years) | - | - | - | - | - | - | 3.779 | 2.006 - 7.118 | <0.001 |
WHO Grading (G 1/2 vs. G 3) | 2.631 | 1.038 - 6.667 | 0.041 | - | - | - | 2.214 | 1.158 - 4.231 | 0.016 |
FIGO Stage (1/2 vs. 3/4) | 7.827 | 3.176 - 19.288 | <0.001 | 3.870 | 1.461 - 10.254 | 0.006 | 2.874 | 1.460 - 5.655 | 0.002 |
Cervical involvement | 2.861 | 1.190 - 6.878 | 0.019 | 3.403 | 1.333 - 8.690 | 0.010 | 3.456 | 1.742 - 6.856 | <0.001 |
Deep myometrial invasion | Â | Â | Â | 3.172 | 1.461 - 10.254 | 0.019 | Â | Â | Â |
Performed Lymphadenectomy | 0.376 | 0.162 - 0.871 | 0.022 | 0.308 | 0.134 - 0.706 | 0.005 | 0.403 | 0.234 - 0.695 | 0.001 |